"Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial." The Lancet, vol
Think of it like physical therapy: you see small improvements quickly, but major results take time
The big question is whether the health of the individual improved with that loss of body weight
Physiological Advantage Unlike simultaneous injections of growth hormone, tesamorelin instead generates pulsatile patterns of natural growth hormone release that closely mimic the normal rhythm of endocrine patterns
Weigh the pros and cons, and talk to a healthcare professional to determine if its a good choice for you
Young Adults With Anterior Ischemic Optic Neuropathy: A Multicenter Optic Disc Drusen Study